Correlation Between Werewolf Therapeutics and Prelude Therapeutics
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and Prelude Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and Prelude Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and Prelude Therapeutics, you can compare the effects of market volatilities on Werewolf Therapeutics and Prelude Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of Prelude Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and Prelude Therapeutics.
Diversification Opportunities for Werewolf Therapeutics and Prelude Therapeutics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Werewolf and Prelude is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and Prelude Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prelude Therapeutics and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with Prelude Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prelude Therapeutics has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and Prelude Therapeutics go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and Prelude Therapeutics
Given the investment horizon of 90 days Werewolf Therapeutics is expected to generate 1.08 times more return on investment than Prelude Therapeutics. However, Werewolf Therapeutics is 1.08 times more volatile than Prelude Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Prelude Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 348.00 in Werewolf Therapeutics on August 31, 2024 and sell it today you would lose (148.00) from holding Werewolf Therapeutics or give up 42.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Werewolf Therapeutics vs. Prelude Therapeutics
Performance |
| Timeline |
| Werewolf Therapeutics |
| Prelude Therapeutics |
Werewolf Therapeutics and Prelude Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Werewolf Therapeutics and Prelude Therapeutics
The main advantage of trading using opposite Werewolf Therapeutics and Prelude Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, Prelude Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prelude Therapeutics will offset losses from the drop in Prelude Therapeutics' long position.| Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
| Prelude Therapeutics vs. Foghorn Therapeutics | Prelude Therapeutics vs. Shattuck Labs | Prelude Therapeutics vs. Monte Rosa Therapeutics | Prelude Therapeutics vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |